Literature DB >> 25491470

Behavioral effects of levodopa.

Isabelle Beaulieu-Boire1, Anthony E Lang.   

Abstract

In recent years, levodopa-induced behavioral changes have received increased attention in the medical literature and in clinical practice. The spectrum of these symptoms includes non-motor fluctuations with neuropsychiatric symptoms, compulsive behaviors such as punding, dopamine dysregulation syndrome, and impulse control disorders, psychosis and hallucinations, as well as hypomania and mania. Despite knowledge of the clinical features associated with these behaviors, many of them are probably underdiagnosed. Although the mechanisms underlying behavioral symptoms are still incompletely understood, recent data from imaging and pathological studies have increased our understanding and guided new treatment strategies. Appropriate management remains challenging, because reduction of levodopa (l-dopa) and dopaminergic treatment is often recommended; however, doses required for control of motor symptoms may still induce behavioral changes. Newer modes of delivery of dopaminergic treatment, deep brain stimulation, and nondopaminergic agents may either provide alternatives for treatment of these behavioral problems or permit treatment of parkinsonism with less risk of these behavioral disorders.
© 2014 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  Behavioral effects; Dopamine dysregulation; Impulse control; Levodopa; Mania; Parkison's Disease; Psychosis; Punding

Mesh:

Substances:

Year:  2014        PMID: 25491470     DOI: 10.1002/mds.26121

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  23 in total

1.  Homicidality and Psychosis Caused by an Over-the-Counter Performance-Enhancing Supplement Containing Dendrobium Extract and L-Dopa.

Authors:  Alexandra Flynn; Jana Lincoln; Michael Burke
Journal:  P T       Date:  2016-06

2.  Exacerbation of psychosis triggered by a synthetic cannabinoid in a 70-year-old woman with Parkinson disease.

Authors:  Sean J Udow; Maria Eliza Freitas; Susan H Fox; Anthony E Lang
Journal:  CMAJ       Date:  2018-01-15       Impact factor: 8.262

3.  Pituitary Adenylate Cyclase Activating Polypeptide Inhibits A10 Dopamine Neurons and Suppresses the Binge-like Consumption of Palatable Food.

Authors:  Nikki Le; Jennifer Hernandez; Cassandra Gastelum; Lynnea Perez; Isabella Vahrson; Sarah Sayers; Edward J Wagner
Journal:  Neuroscience       Date:  2021-09-28       Impact factor: 3.590

4.  Manic symptom severity correlates with COMT activity in the striatum: A post-mortem study.

Authors:  Marco Bortolato; Consuelo Walss-Bass; Peter M Thompson; Jackob Moskovitz
Journal:  World J Biol Psychiatry       Date:  2016-07-26       Impact factor: 4.132

5.  Using Intermediate Cognitive Endpoints to Facilitate Translational Research in Psychosis.

Authors:  Gary Gilmour; Francois Gastambide; Hugh M Marston; Mark E Walton
Journal:  Curr Opin Behav Sci       Date:  2015-08-01

6.  Dopamine Release in the Nonhuman Primate Caudate and Putamen Depends upon Site of Stimulation in the Subthalamic Nucleus.

Authors:  Hoon-Ki Min; Erika K Ross; Hang Joon Jo; Shinho Cho; Megan L Settell; Ju Ho Jeong; Penelope S Duffy; Su-Youne Chang; Kevin E Bennet; Charles D Blaha; Kendall H Lee
Journal:  J Neurosci       Date:  2016-06-01       Impact factor: 6.167

Review 7.  "Pseudo-syndromes" associated with Parkinson disease, dementia, apathy, anxiety, and depression.

Authors:  Howard D Weiss; Gregory M Pontone
Journal:  Neurol Clin Pract       Date:  2019-08

8.  Further characterisation of psychosis-like behaviours induced by L-DOPA in the MPTP-lesioned marmoset.

Authors:  Cynthia Kwan; Stephen G Nuara; Jim C Gourdon; Philippe Huot
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-05-08       Impact factor: 3.000

9.  Does antiretroviral therapy alter the course of Parkinson's disease in people living with HIV?

Authors:  Ferzana Hassan Amod; Ahmed Iqbal Bhigjee; Anand Moodley
Journal:  J Neurovirol       Date:  2021-08-05       Impact factor: 2.643

10.  Functional Magnetic Resonance Imaging Neurofeedback-guided Motor Imagery Training and Motor Training for Parkinson's Disease: Randomized Trial.

Authors:  Leena Subramanian; Monica Busse Morris; Meadhbh Brosnan; Duncan L Turner; Huw R Morris; David E J Linden
Journal:  Front Behav Neurosci       Date:  2016-06-08       Impact factor: 3.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.